On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
about
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needsRecovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
P2860
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@ast
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@en
type
label
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@ast
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@en
prefLabel
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@ast
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@en
P2093
P2860
P50
P1433
P1476
On-treatment decrease of NKG2D ...... herapy for chronic hepatitis C
@en
P2093
Akihiko Ikura
Akihiro Yamaguchi
Aya Ugamura
Hiroko Murata
Hirotoshi Ebinuma
Karin Takeda
Keisuke Ojiro
Nobuhiro Nakamoto
Nobuhito Taniki
Rei Miyake
P2860
P304
P356
10.1371/JOURNAL.PONE.0179096
P407
P577
2017-06-15T00:00:00Z